Label Changes for:

Alimta (pemetrexed disodium) Injection, Powder, Lyophilized for Intravenous Use 100 mg and 500 mg vial

July 2009

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

ADVERSE REACTIONS

Post-Marketing Experience
Hide
(web5)